Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 471-479

  Marangoni, Antonella ^a   Fiorino, Erika ^b   Gilardi, Federica ^b,c   Aldini, Rita ^a   Scotti, Elena ^b,d   Nardini, Paola ^a   Foschi, Claudio ^a   Donati, Manuela ^a   Montagnani, Marco ^a   Cevenini, Monica ^a   Franco, Placido ^a   Roda, Aldo ^a   Crestani, Maurizio ^b   Cevenini, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d ETH ZURICH   (Switzerland)

Author keywords

Atherosclerosis; C.pneumoniae; Carnitine palmitoyltransferase; Cholesterol; Cholesterol 7 hydroxylase; Inducible nitric oxide synthase; Interleukin 1 ; Low density lipoprotein receptor; Low density lipoprotein receptor degrader; Medium chain acyl CoA dehydrogenase

Indexed keywords

ACETYL COA CARBOXYLASE 1; ACETYL COENZYME A CARBOXYLASE; BILE ACID; BUFFER; CARNITINE PALMITOYLTRANSFERASE 1A; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOKINE; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUCROSE PHOSPHATE GLUTAMATE BUFFER; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACYL COENZYME A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE; GLUTAMIC ACID; LIPID; PHOSPHATE; SUCROSE;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; GENE DISRUPTION; GENE EXPRESSION; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATOR GENE; SEROTYPE; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; TRIGLYCERIDE METABOLISM; ACUTE LIVER FAILURE; ANIMAL; ATHEROSCLEROSIS; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; CHLAMYDIA PNEUMONIAE; CHLAMYDIASIS; COMPLICATION; GENE EXPRESSION REGULATION; LIVER; METABOLISM; MICROBIOLOGY; PARENTERAL DRUG ADMINISTRATION;

ACYL-COA DEHYDROGENASE; ANIMALS; ATHEROSCLEROSIS; BILE ACIDS AND SALTS; CARNITINE O-PALMITOYLTRANSFERASE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; CYTOKINES; GENE EXPRESSION REGULATION; GLUTAMIC ACID; INFLAMMATION; INFUSIONS, PARENTERAL; LIPID METABOLISM; LIPIDS; LIVER; LIVER FAILURE, ACUTE; MALE; MICE; MICE, INBRED BALB C; PHOSPHATES; SUCROSE; TRIGLYCERIDES;

EID: 84931275161     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.023     Document Type: Article

References (50)

1. Wu J.T., Wu L.L. Linking inflammation and atherogenesis: soluble markers identified for the detection of risk factors and for early risk assessment. Clin. Chim. Acta 2006, 366(1-2):74-80.
2. Morré S.A., Stooker W., Lagrand W.K., van den Brule A.J., Niessen H.W. Microorganisms in the aetiology of atherosclerosis. J.Clin. Pathol. 2000, 53(9):647-654.
3. Patel P.N., Shah R.Y., Ferguson J.F., Reilly M.P. Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics ofInnate immunity in complex cardiometabolic diseases. Arterioscler. Thromb. Vasc. Biol. 2015, 35(3):525-534. 10.1161/ATVBAHA.114.304455.
4. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2(8618):983-986.
5. Armingohar Z., Jørgensen J.J., Kristoffersen A.K., Abesha-Belay E., Olsen I. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. J.Oral Microbiol. 2014, 6. (eCollection). 10.3402/jom.v6.23408.
6. Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J.Infect. Dis. 1993, 167(4):841-849.
7. Post W.S., George R.T., Budoff M. HIV infection and subclinical coronary atherosclerosis. Ann. Intern Med. 2014 Dec 16, 161(12):923-924.
8. Takaoka N., Campbell L.A., Lee A., Rosenfeld M.E., Kuo C.C. Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells invitro and to aortas exvivo. Infect. Immun. 2008, 76(2):510-514.
9. Tuomainen A.M., Hyvärinen K., Ehlers P.I., Mervaala E., Leinonen M., Saikku P., Kovanen P.T., Jauhiainen M., Pussinen P.J. The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice. Microb. Pathog. 2011, 51(3):217-224.
10. Hyvärinen K., Tuomainen A.M., Laitinen S., Bykov I.L., Törmäkangas L., Lindros K., Käkelä R., Alfthan G., Salminen I., Jauhiainen M., Kovanen P.T., Leinonen M., Saikku P., Pussinen P.J. Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice. Infect. Immun. 2009, 77(8):3442-3449.
11. Uchiumi D., Kobayashi M., Tachikawa T., Hasegawa K. Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. J.Periodontal Res. 2004, 39(2):120-128.
12. Grunfeld C., Feingold K.R. Tumor necrosis factor, interleukin, and interferon induced changes in lipid metabolism as part of host defense. Proc. Soc. Exp. Biol. Med. 1992, 200(2):224-227.
13. Harris H.W., Grunfeld C., Feingold K.R., Rapp J.H. Human very low density lipoproteins and chylomicrons can protect against endotoxin induced death in mice. J.Clin. Invest 1990, 86(3):696-702.
14. Consoli D., Vidale S., Aguglia U., Bassi P., Cavallini A., Galati F., Guidetti D., Marcello N., Micieli G., Pracucci G., Rasura M., Siniscalchi A., Sterzi R., Toni D., Inzitari D. Previous infection and the risk of ischaemic stroke in Italy: the IN2study. Eur. J. Neurol. 2015, 22(3):514-519. 10.1111/ene.12601.
15. Yang Z.P., Kuo C.C., Grayston J.T. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J.Infect. Dis. 1995, 171(3):736-738.
16. Moazed T.C., Kuo C.C., Grayston J.T., Campbell L.A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J.Infect. Dis. 1998, 177(5):1322-1325.
17. Marangoni A., Bergamini C., Fato R., Cavallini C., Donati M., Nardini P., Foschi C., Cevenini R. Infection of human monocytes by Chlamydia pneumoniae and Chlamydia trachomatis: an invitro comparative study. BMC Res. Notes 2014, 7:230. 10.1186/1756-0500-7-230.
18. Marangoni A., Donati M., Cavrini F., Aldini R., Accardo S., Sambri V., Montagnani M., Cevenini R. Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. World J. Gastroenterol. 2006, 12(40):6453-6457.
19. Molestina R.E., Miller R.D., Ramirez J.A., Summersgill J.T. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect. Immun. 1999, 67(3):1323-1330.
20. Erkkilä L., Laitinen K., Haasio K., Tiirola T., Jauhiainen M., Lehr H.A., Aalto-Setälä K., Saikku P., Leinonen M. Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JB mice during Chlamydia pneumoniae infection. Atherosclerosis 2004, 177(2):321-328.
21. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1997, 17(11):2910-2913.
22. Watson C., Alp N.J. Role of Chlamydia pneumoniae in atherosclerosis. Clin. Sci. (Lond) 2008, 114(8):509-531.
23. Abdulkarim A.S., Petrovic L.M., Kim W.R. Primary biliary chirrosis: an infectious disease caused by Chlamydia pneumoniae?. J.Hepatol. 2004, 40(3):380-384.
24. De Fabiani E., Mitro N., Anzulovich A.C., Pinelli A., Galli G., Crestani M. The negative effect of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J.Biol. Chem. 2001, 276(33):30708-30716.
25. European Centre for Disease Prevention and Control Sexually Transmitted Infections in Europe 2011 2013, ECDC, Stockholm, Sweden. 10.2900/52553.
26. Dan M., Tyrrell L.D.J., Goldsand G. Isolation of Chlamydia trachomatis from the liver of patients with prolonged fever. Gut 1987, 28(11):1514-1516.
27. Bashmakov Y.K., Zigangirova N.A., Pashko Y.P., Kapotina L.N., Petyaev I.M. Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin. Comp. Hepatol. 2010, 9:3. 10.1186/1476-5926-9-3.
28. Montigiani S., Falugi F., Scarselli M., Finco O., Petracca R., Galli G., Mariani M., Manetti R., Agnusdei M., Cevenini R., Donati M., Nogarotto R., Norais N., Garaguso I., Nuti S., Saletti G., Rosa D., Ratti G., Grandi G. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect. Immun. 2002, 70(1):368-379.
29. Finco O., Frigimelica E., Buricchi F., Petracca R., Galli G., Faenzi E., Meoni E., Bonci A., Agnusdei M., Nardelli F., Bartolini E., Scarselli M., Caproni E., Laera D., Zedda L., Skibinski D., Giovinazzi S., Bastone R., Ianni E., Cevenini R., Grandi G., Grifantini R. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(24):9969-9974.
30. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., Denk H., Desmet V., Korb G., Mac Sween R.N. Histological grading and staging of chronic hepatitis. J.Hepatol. 1995, 6:696-699.
31. Roda A., Pellicciari R., Gioiello A., Neri F., Camborata C., Passeri D., De Franco F., Spinozzi S., Colliva C., Adorini L., Montagnani M., Aldini R. Semisynthetic bile acid FXR and TGR5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat. J.Pharmacol. Exp. Ther. 2014, 350(1):56-68. 10.1124/jpet.114.214650.
32. Porcelli L., Gilardi F., Laghezza A., Piemontese L., Mitro N., Azzariti A., Altieri F., Cervoni L., Fracchiolla G., Giudici M., Guerrini U., Lavecchia A., Montanari R., Di Giovanni C., Paradiso A., Pochetti G., Simone G.M., Tortorella P., Crestani M., Loiodice F. Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity. J.Med. Chem. 2012 Jan 12, 55(1):37-54. 10.1021/jm201306q.
33. Galmozzi A., Mitro N., Ferrari A., Gers E., Gilardi F., Godio C., Cermenati G., Gualerzi A., Donetti E., Rotili D., Valente S., Guerrini U., Caruso D., Mai A., Saez E., De Fabiani E., Crestani M. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 2013, 62(3):732-742.
34. Gilardi F., Giudici M., Mitro N., Maschi O., Guerrini U., Rando G., Maggi A., Cermenati G., Laghezza A., Loiodice F., Pochetti G., Lavecchia A., Caruso D., De Fabiani E., Bamberg K., Crestani M. J.Biol. Chem. 2014, 289(10):6908-6920. 10.1074/jbc.M113.506394.
35. Liu W., He P., Cheng B., Mei C.L., Wang Y.F., Wan J.J. Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways. Microbes Infect. 2010, 12(14-15):1226-1235.
36. Campbell L.A., Rosenfeld M.E. Persistent C.pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Front. Cell. Infect. Microbiol. 2014, 4:34. eCollection 2014. 10.3389/fcimb.2014.00034.
37. Cannon C.P., Braunwald E., McCabe C.H., Grayston J.T., Muhlestein B., Giugliano R.P., Cairns R., Skene A.M. Pravastatin or Atorvastatin evaluation and infection therapy-Thrombolysis in myocardial infarction 22 Investigators, antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N.Engl. J. Med. 2005, 352(16):1646-1654.
38. O'Connor C.M., Dunne M.W., Pfeffer M.A., Yao L., Gupta S., Benner R.J., Fisher M.R., CooK T.D. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 2003, 290(11):1459-1466.
39. Naiki Y., Sorrentino R., Wong M.H., Michelsen K.S., Shimada K., Chen S., Yilmaz A., Slepenkin A., Schröder N.W., Crother T.R., Bulut Y., Doherty T.M., Bradley M., Shaposhnik Z., Peterson E.M., Tontonoz P., Shah P.K., Arditi M. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J.Immunol. 2008, 181(10):7176-7185.
40. Ponugoti B., Fang S., Kim Kemper J. Functional interaction of hepatic nuclear Factor-4 and peroxisome proliferator-activated receptor-γ coactivator 1α in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c. Mol. Endocrinol. 2007, 21(11):2698-2712.
41. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93:693-704.
42. Blessing E., Campbell L.A., Rosenfeld M.E., Chough N., Kuo C.C. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 2001, 158(1):13-17.
43. Michelini E., Donati M., Aldini R., Cevenini L., Mezzanotte L., Nardini P., Foschi C., Zvi I.B., Cevenini M., Montagnani M., Marangoni A., Roda A., Cevenini R. Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. Anal. Biochem. 2011, 430(1):92-96.
44. Campbell L.A., Yaraei K., Van Lenten B., Chait A., Blessing E., Kuo C.C., Nosaka T., Ricks J., Rosenfeld M.E. The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis. Microbes Infect. 2010, 12(8-9):598-606.
45. Chiang J.Y. Bile acids: regulation of synthesis. J.Lipid Res. 2009, 50(10):1955-1966. 10.1194/jlr.R900010-JLR200.
46. Makarova K.S., Aravind L., Koonin E.V. Anovel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 2000, 25:50-52.
47. Liao W., Rudling M., Angelin B. Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4. Hepatology 1999, 30(5):1252-1256.
48. Barke R.A., Birklid S., Chapin R.B., Roy S., Brady P.S., Brady L.J. The effect of surgical treatment following peritoneal sepsis on hepatic gene expression. J.Surg. Res. 1996, 60(1):101-106.
49. Törmäkangas L., Erkkilä L., Korhonen T., Tiirola T., Bloiqu A., Saikku P., Leinonen M. Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect. Immun. 2005, 73(10):6458-6466.
50. Blessing E., Nagano S., Campbell L.A., Rosenfeld M.E., Kuo C.C. Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infect. Immun. 2000, 68(12):7195-7197.